儿童重型COVID-19表现为呼吸衰竭和重度血小板减少
本文报告一名既往健康的12岁女孩,以发热、咳嗽、呕吐起病,实验室检查示重度血小板减少和炎症标志物升高,病情进展至呼吸衰竭,SARS-CoV-2检测阳性。针对血小板减少使用静脉免疫球蛋白和激素后血小板迅速改善,重度ARDS经机械通气、吸入一氧化氮及气道压力释放通气管理,在阿奇霉素和羟氯喹无效后使用托珠单抗和瑞德西韦获得显著临床获益。
要点
- 既往健康儿童也可发生重型COVID-19并进展为呼吸衰竭。
- 儿童重型COVID-19可伴重度血小板减少,需警惕出血风险。
- 该病例在抗炎及抗病毒治疗后获得显著临床获益。
核心结论
- 既往无基础疾病的12岁女孩可发生重型COVID-19,表现为呼吸衰竭和重度血小板减少。
研究设计与样本
- 本文为单例病例报告,对象为一名既往无病史的12岁女孩。
主要发现
- 患者以发热、咳嗽、呕吐起病,实验室检查示重度血小板减少和炎症标志物升高。
- 患者病情进展至呼吸衰竭,SARS-CoV-2检测结果阳性。
- 针对血小板减少使用静脉免疫球蛋白和激素后血小板迅速改善。
- 重度ARDS经机械通气、吸入一氧化氮及气道压力释放通气管理。
- 阿奇霉素和羟氯喹治疗后无改善,改用托珠单抗和瑞德西韦后不久获得显著临床获益。
临床怎么用
- 儿科医生应认识到既往健康儿童也可能出现重型COVID-19并快速进展。
- 对重型COVID-19患儿应监测血小板及炎症标志物,警惕重度血小板减少。
- 本病例中静脉免疫球蛋白和激素用于重度血小板减少后血小板迅速改善。
- 本病例中托珠单抗和瑞德西韦在阿奇霉素和羟氯喹无效后使用并获得显著临床获益。
局限性
- 本文为单例病例报告,不能据此推断因果关系或推广至其他患儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The novel severe acute respiratory syndrome coronavirus 2 is a worldwide pandemic. The severe morbidity and mortality associated with coronavirus disease 2019 has mostly affected the elderly or those with underlying medical conditions. We present a case of a 12-year-old girl with no past medical history who presented with fever, cough, and vomiting. Laboratory evaluation revealed severe thrombocytopenia and elevated markers of inflammation. The patient progressed to respiratory failure, and testing results for the severe acute respiratory syndrome coronavirus 2 returned positive. Because of the severity of her thrombocytopenia, she was treated with intravenous immunoglobulin and steroids with prompt improvement in platelets. The patient's severe acute respiratory distress syndrome was managed with mechanical ventilation, inhaled nitric oxide, and then airway pressure release ventilation. After azithromycin and hydroxychloroquine were given without improvement, our patient received tocilizumab, an anti-interleukin-6 receptor antibody, and remdesivir, a broad antiviral agent, with significant clinical benefit soon afterward. Given that severe pediatric coronavirus disease 2019 is rare, we hope to inform pediatric providers on the clinical course and management considerations as this pandemic continues to spread.
引用
- Patel PA, Chandrakasan S, Mickells GE, et al. Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia. Pediatrics. 2020. PMID: 32366611. doi:10.1542/peds.2020-1437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。